Press Releases
Please, enter cell line, author or any other phrase or word you would like to search for.
PHI announces significant order agreement from Altium for 20 HoloMonitor systems
PHI is excited to announce a significant order agreement from Altium for 20 HoloMonitor systems, which will be shipped in the second half of 2024.
The exercise period for warrants of series TO 4 commences today
Today is the first day for the exercise of Phase Holographic Imaging PHI AB’s warrants of series TO 4 which were issued in connection with the preferential issue of units that the Company carried out during 2022. The period lasts until October 3, 2024.
The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share
PHI announces that the exercise price for warrants of series TO 4 has been set at SEK 4.63 per new share.
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 2 September 2024
Phase Holographic Imaging PHI AB (publ) (“PHI” or the “Company”) held an extraordinary general meeting on 2 September 2024. The following resolutions were passed at the meeting.
PHI enters the US capital market – shares now also traded on OTCQB
PHI is thrilled to announce its official approval for also listing on the OTCQB Venture Market in the U.S., with trading commencing Thursday, August 15th. (OTCQB:PHIXF).
New date: Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 2 September 2024
Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the “Company”), will hold an extraordinary general meeting on 2 September at 14.00 at the Company’s premises at Skiffervägen 48 in Lund.
PHI postpones the extraordinary general meeting until September 2, 2024
The Board of Directors of PHI AB has decided to postpone the date of the extraordinary general meeting until September 2, 2024. An updated notice for the extraordinary general meeting will be issued shortly.
Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 19 August 2024
Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the “Company”), will hold an extraordinary general meeting on 19 August at 14:00 at the Company’s premises at Skiffervägen 48 in Lund.
Board member Leland Foster resigns due to personal reasons
PHI announces the resignation of esteemed board member Leland Foster. Mr. Foster has decided to resign from his position due to his age and his desire to retire from professional commitments. After this, the Board of Directors continues to have a quorum in accordance with the Articles of Association.
PHI applies for listing on OTCQB in the United States
PHI is pursuing a dual listing on the US-based OTCQB Venture Market to provide US-based investors with the ability to invest in PHI. PHI aims to solidify further its presence in the major US market and within regenerative medicine, a rapidly evolving field, spearheaded by the United States globally. The application process has been initiated, and PHI expects to receive approval in the third quarter of 2024.